BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33351555)

  • 1. Treatment Analysis and Overall Survival Outcomes of Patients With Bilateral Vestibular Schwannoma.
    Goshtasbi K; Abouzari M; Yasaka TM; Soltanzadeh-Zarandi S; Sarna B; Lin HW; Djalilian HR
    Otol Neurotol; 2021 Apr; 42(4):592-597. PubMed ID: 33351555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
    Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
    J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations.
    Mahboubi H; Maducdoc MM; Yau AY; Ziai K; Ghavami Y; Badran KW; Al-Thobaiti M; Brandon B; Djalilian HR
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):822-31. PubMed ID: 25791708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
    Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
    J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
    Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
    Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
    Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cochlear implantation after radiosurgery for vestibular schwannoma.
    Patel NS; Carlson ML; Link MJ; Neff BA; Van Gompel JJ; Driscoll CLW
    J Neurosurg; 2021 Jul; 135(1):126-135. PubMed ID: 34250789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochlear Implant Outcomes between Patients with Sporadic and Neurofibromatosis Type 2-Associated Vestibular Schwannoma.
    Dornhoffer JR; Haller T; Lohse CM; Driscoll CLW; Neff BA; Saoji A; Link MJ; Carlson ML
    Otol Neurotol; 2023 Sep; 44(8):791-797. PubMed ID: 37464449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls.
    Carlson ML; Tveiten OV; Driscoll CL; Goplen FK; Neff BA; Pollock BE; Tombers NM; Castner ML; Finnkirk MK; Myrseth E; Pedersen PH; Lund-Johansen M; Link MJ
    J Neurosurg; 2015 Apr; 122(4):833-42. PubMed ID: 25555165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and analysis of long-term headache in sporadic vestibular schwannoma: a multicenter cross-sectional study.
    Carlson ML; Tveiten ØV; Driscoll CL; Boes CJ; Sullan MJ; Goplen FK; Lund-Johansen M; Link MJ
    J Neurosurg; 2015 Nov; 123(5):1276-86. PubMed ID: 26090830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
    Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
    J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Control and Hearing Preservation After Gamma Knife Radiosurgery for Vestibular Schwannomas in Neurofibromatosis Type 2-A Retrospective Analysis of 133 Tumors.
    Sri Krishna GS; Pahwa B; Jagdevan A; Singh M; Kale S; Agrawal D
    World Neurosurg; 2023 Mar; 171():e820-e827. PubMed ID: 36587894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of vestibular schwannomas and hearing loss in NF2 patients.
    Peyre M; Bernardeschi D; Sterkers O; Kalamarides M
    Neurochirurgie; 2018 Nov; 64(5):342-347. PubMed ID: 26183546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial Nerve Outcomes After Vestibular Schwannoma Microsurgical Resection in Neurofibromatosis Type 2.
    Sobieski C; Killeen DE; Barnett SL; Mickey BE; Hunter JB; Isaacson B; Kutz JW
    Otolaryngol Head Neck Surg; 2021 Apr; 164(4):850-858. PubMed ID: 32957864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vestibular schwannoma: role of conservative management.
    Suryanarayanan R; Ramsden RT; Saeed SR; Aggarwal R; King AT; Rutherford SA; Evans DG; Gillespie JE
    J Laryngol Otol; 2010 Mar; 124(3):251-7. PubMed ID: 20003606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of Gamma-knife stereotactic radiosurgery for vestibular schwannomas in patients with type 2 neurofibromatosis.
    Spatola G; Carron R; Delsanti C; Thomassin JM; Roche PH; Régis J
    Neurochirurgie; 2018 Nov; 64(5):355-363. PubMed ID: 27527622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery.
    Yang I; Sughrue ME; Han SJ; Fang S; Aranda D; Cheung SW; Pitts LH; Parsa AT
    J Neurooncol; 2009 May; 93(1):41-8. PubMed ID: 19430881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment growth rate as a predictor of tumor control following Gamma Knife radiosurgery for sporadic vestibular schwannoma.
    Marston AP; Jacob JT; Carlson ML; Pollock BE; Driscoll CLW; Link MJ
    J Neurosurg; 2017 Aug; 127(2):380-387. PubMed ID: 27885952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.